The Netherlands
Corporis Medical, founded in 2015 and headquartered in The Netherlands, is on the cutting edge of the Medical Devices industry. Specializing in the development and commercialization of pioneering surgical devices, the company aims to significantly enhance surgical outcomes.
Guided by the expertise of surgeon and founder, Dr. Alexander Veenhof, Corporis Medical addresses critical surgical challenges inspired by his experiences in oncologic surgery. The startup is actively commercializing two promising devices: Laprixa™ and Mediclose™. Laprixa™ offers a novel approach to assessing bowel tissue healing capacity during surgery, potentially reducing life-threatening complications like anastomotic leakage. Meanwhile, Mediclose™ enhances laparoscopic wound closure techniques, minimizing risks of improper healing and subsequent herniation.
In December 2023, Corporis Medical secured a €4.00M Series B investment from Unorthodox Ventures, NV Industriebank LIOF, and Brightlands Venture Partners, underscoring investor confidence in its innovative solutions.
